Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trialPaul M. Ridker, Hakan Kültürsay, Jean MacFadyen et al.|The Lancet|2017Cited by 1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialPaul M. Ridker, Patrick Commerford, Peter Siostrzonek et al.|The Lancet|2017Cited by 881
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular DiseaseHyun Kuk Kim, Young‐Hoon Jeong, Udaya S. Tantry et al.|Thrombosis and Haemostasis|2020Cited by 334
Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in ChineseClara Sze-Man Tang, Hung‐Fat Tse, He Zhang et al.|Nature Communications|2015Cited by 135
Interaction of serum vitamin B <sub>12</sub> and folate with <i>MTHFR</i> genotypes on risk of ischemic strokeXianhui Qin, Yong Huo, J. David Spence et al.|Neurology|2020Cited by 70